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Objective: This review was conducted to determine the optimal timing for referring patients with end-stage renal disease
to vascular surgery for access placement.
Methods:A systematic review of the electronic databases (MEDLINE, EMBASE, Current Contents, Cochrane CENTRAL
and Web of Science) was conducted through March 2007. Randomized and observational studies were eligible if they
compared an early referral cohort with a late referral cohort in terms of patient-important outcomes such as death,
access-related sepsis, and hospitalization related to access complications.
Results: We found no studies that fulfilled eligibility criteria.
Conclusion: At the present time, the optimal timing for referral to vascular surgery for vascular access placement is based
on expert opinion and choices made by patients and physicians. ( J Vasc Surg 2008;48:31S-33S.)A consensus statement by the vascular access group of
the National Kidney Foundation Kidney Disease Out-
comes Quality Initiative (NKF KDOQI) recommended
that patients with chronic kidney disease should be referred
for surgery to attempt the construction of a primary arte-
riovenous (AV) autogenous access when their creatinine
clearance is 25 mL/min, their serum creatinine level is
4 mg/dL, or1 year of an anticipated need for dialysis.1
However, guideline authors acknowledged at the time
that this recommendation was only based on experts’
opinions.
The Society for Vascular Surgery has formed a multi-
specialty committee to develop guidelines for the manage-
ment of vascular access for hemodialysis. To assist in this
process, this task force required the conduct of a systematic
review of the best available research evidence on this topic.
Because the availability of a functional arteriovenous access
when the patient is ready for dialysis is very important to
avoid placement of temporary dialysis catheters, known for
a high rate of complications, the Society specifically re-
quested a study on the issue of the timing of referral of
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METHODS
Eligibility criteria. We searched for randomized con-
trolled trials (RCTs), cohort studies, and studies with
nested case-control designs that compared patients who
were referred to vascular surgery for access placement at
different time intervals before the start of hemodialysis.
Studies were eligible regardless of their publication status,
language, size, duration of patient follow-up, or their pri-
mary objectives. The outcomes of interest were death,
access-related sepsis, and hospitalization related to access
complications.
Study identification. An expert reference librarian
designed and conducted the electronic search strategy with
input from study investigators with expertise in conducting
systematic reviews. To identify eligible studies, we searched
electronic databases (MEDLINE, EMBASE, Current Con-
tents, Cochrane CENTRAL and Web of Science) through
March 2007. Subject headings and keywords were selected
to describe hemodialysis, including the MeSH terms exp
renal dialysis, renal replacement therapy, or exp renal insuf-
ficiency, chronic. Then, we used subject headings and key-
words to describe the intervention, including arteriovenous
fistula, arteriovenous shunt, surgical, vascular access, and
vascular grafts. The results were limited using the Haynes
filter for clinical trials. The concept of timing was described
by using the keywords timing, before, early, or late. These
strategies were adapted with some modifications in
EMBASE, CENTRAL, and Current Contents/Web of
Science. We also sought references from experts.
References were uploaded in a Web-based software
package developed for systematic review data management
31S
s stu
JOURNAL OF VASCULAR SURGERY
November Supplement 200832S Murad et al(SRS, TrialStat Corp, Ottawa, Ontario, Canada). Paired
reviewers working independently screened all abstracts and
titles for eligibility. References that were deemed poten-
tially relevant were retrieved in full text and uploaded for a
full-text evaluation against eligibility criteria. The chance-
adjusted inter-reviewer agreement ( statistic) was 0.85.
Disagreements were resolved by consensus (the two re-
viewers discussed the study and reached a consensus) and
by arbitration (a third reviewer adjudicated the study) when
disagreement continued.
RESULTS
We reviewed 468 potentially relevant articles identified
by search and selected 107 articles for full text retrieval. We
found no studies that fulfilled the eligibility criteria. The
study selection process is described in the Fig.
We found two studies that did not fulfill the eligibility
criteria of this review but provided indirect evidence that
early referral to vascular surgery may improve patient out-
comes. Besarab et al2 studied 1411 patients who started
chronic hemodialysis in the Renal Network of the Upper
Midwest. They reported that 5% of patients who were
seen by a vascular surgeon more than 1 month before
hemodialysis used a catheter as their first access. Consider-
ing catheter use as a potential surrogate for increased
incidence of sepsis and death, this study indirectly supports
early referral to a vascular surgeon.2
The second study, by Oliver et al,3 used Canadian
administrative and billing databases to determine whether
the timing of access placement was associated with in-
creased risk of hospitalization for sepsis or death. We con-
sidered this study to indirectly answer the question of this
review because they evaluated the timing of actual access
placement and not the timing of referral. Access placement
is influenced by factors other than referral, for example,
patient’s acceptance of the procedure and insurance deci-
sions, among others. Furthermore, the outcome of sepsis
was based on hospitalization for any bacteremia or sepsis
and not necessarily for access-related infections. They iden-
tified 5924 incident hemodialysis patients and monitored
them for 1 year from the start of hemodialysis. Compared
with late access construction (1 month of hemodialysis),
Fig. Flow chart showearly access construction (4 months before hemodialysis)was associated with lower risk of death and sepsis, with
relative risks of 0.76 (95% confidence interval [CI], 0.58-
1.00) and 0.57 (95% CI, 0.41-0.79) respectively. Introduc-
ing catheter use and sepsis into the mortality model made
the association nonsignificant.3
DISCUSSION
Although ample evidence demonstrates that patients
who are referred early to a nephrologist have better survi-
val,4,5 the decision about when to refer patients to a sur-
geon for AV access placement seems to be based on experts’
inferences drawn from unsystematic clinical observations
and indirect evidence, systemic constraints (eg, reimburse-
ment policies, access to vascular surgery services), and
physician and patient preferences.
Evidence-based guidelines can offer recommendations
in the setting of very low-quality evidence, such as from
unsystematic clinical observations and potentially biased
and confounded observational studies, as long as the evi-
dence brought to bear is explicitly and clearly described.
Often, these recommendations are weak (ie, suggestions),
implying that they should not be used as quality parameters
and clinicians should not be held accountable when depart-
ing from the suggested path. Furthermore, acting on sug-
gestions requires careful attention to systemic constraints
(ie, cost and access to surgery services proficient in the
placement of AV access) and patient values and preferences.
One very important drawback of early placement of an
access is when autogenous venous tissue is not available and
a prosthetic AV access is placed long before dialysis is
initiated. A prosthetic access has a limited life span unre-
lated to whether the access is being used for dialysis, and the
failure of such access is mostly due to the development of
outflow intimal hyperplasia at the venous anastomosis.
Therefore, the early placement of prosthetic access will lead
to its premature failure, sometimes even before dialysis is
initiated. Unfortunately, this extensive review of the evi-
dence failed to provide information on this issue due to
paucity of published data. Clinical practice recommenda-
tions associated with the findings of this systematic review
dy selection process.are published separately.
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Future research is needed to determine the optimal
time for referring patients with chronic kidney disease to
vascular surgery for access placement.
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